Immunopathogenic Background of Pars Planitis

[1]  M. Mochizuki,et al.  Suppression of IL-22-producing T helper 22 cells by RPE cells via PD-L1/PD-1 interactions. , 2013, Investigative ophthalmology & visual science.

[2]  J. Fernández.  Diagnosis and Treatment of Uveitis , 2013 .

[3]  M. Mochizuki,et al.  Mature dendritic cell suppression by IL-1 receptor antagonist on retinal pigment epithelium cells. , 2013, Investigative ophthalmology & visual science.

[4]  M. Schwartz,et al.  Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates , 2013, Nature Reviews Immunology.

[5]  B. Takahashi,et al.  Experimental models of autoimmune inflammatory ocular diseases. , 2012, Arquivos brasileiros de oftalmologia.

[6]  J. Fung,et al.  Myeloid suppressor cells induced by retinal pigment epithelial cells inhibit autoreactive T-cell responses that lead to experimental autoimmune uveitis. , 2012, Investigative ophthalmology & visual science.

[7]  M. Mochizuki,et al.  Suppression of interleukin-17-producing T-helper 17 cells by retinal pigment epithelial cells , 2011, Japanese Journal of Ophthalmology.

[8]  M. Mochizuki,et al.  Inhibition of B-cell activation by retinal pigment epithelium. , 2010, Investigative ophthalmology & visual science.

[9]  J. Bernabeu-Wittel,et al.  Características clínicas, epidemiológicas y asociación con el sistema HLA en pacientes con pars planitis , 2010 .

[10]  C. Peters,et al.  Acquisition of T Regulatory Function in Cathepsin L-Inhibited T Cells by Eye-Derived CTLA-2α during Inflammatory Conditions1 , 2009, The Journal of Immunology.

[11]  N. Acharya,et al.  Ranibizumab for refractory uveitis-related macular edema. , 2009, American journal of ophthalmology.

[12]  A. Rosenthal,et al.  Course and complications of intermediate uveitis. , 2009, Acta ophthalmologica Scandinavica.

[13]  R. Nussenblatt,et al.  CD4+Foxp3+ T-regulatory cells in noninfectious uveitis. , 2009, Archives of ophthalmology.

[14]  Vanita Gupta,et al.  Search for a functional glucocorticoid receptor in the mammalian lens. , 2009, Experimental eye research.

[15]  H. Aburatani,et al.  Retinal Pigment Epithelium-Derived CTLA-2α Induces TGFβ-Producing T Regulatory Cells12 , 2008, The Journal of Immunology.

[16]  E. Ling,et al.  Blood–retinal barrier in hypoxic ischaemic conditions: Basic concepts, clinical features and management , 2008, Progress in Retinal and Eye Research.

[17]  Andrew D. Dick,et al.  The dynamics of leukocyte infiltration in experimental autoimmune uveoretinitis , 2008, Progress in Retinal and Eye Research.

[18]  M. Hudson,et al.  Anterior and intermediate uveitis cases referred to a tertiary centre in Alberta. , 2007, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[19]  J. Pulido,et al.  Pars planitis: a 20-year study of incidence, clinical features, and outcomes. , 2007, American journal of ophthalmology.

[20]  J. Forrester,et al.  Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy. , 2007, Investigative ophthalmology & visual science.

[21]  J. Nickerson,et al.  Hydrodynamic Vaccination with DNA Encoding an Immunologically Privileged Retinal Antigen Protects from Autoimmunity through Induction of Regulatory T Cells1 , 2007, The Journal of Immunology.

[22]  K. Lew,et al.  Interaction of retinal pigmented epithelial cells and CD4 T cells leads to T-cell anergy. , 2007, Investigative ophthalmology & visual science.

[23]  R. Lascuraín,et al.  Pars planitis is associated with an increased frequency of effector-memory CD57+ T cells , 2007, British Journal of Ophthalmology.

[24]  H. Kaplan,et al.  Minimally activated CD8 autoreactive T cells specific for IRBP express a high level of Foxp3 and are functionally suppressive. , 2007, Investigative ophthalmology & visual science.

[25]  M. Zierhut,et al.  High incidence of antibodies to lens proteins in sera from patients with uveitis , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.

[26]  J. Forrester,et al.  CD4+CD25+ T regulatory cells induced by LPS-activated bone marrow dendritic cells suppress experimental autoimmune uveoretinitis in vivo , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.

[27]  M. Mochizuki,et al.  Retinal and ciliary body pigment epithelium suppress activation of T lymphocytes via transforming growth factor beta. , 2006, Experimental eye research.

[28]  M. Mochizuki,et al.  B7+ iris pigment epithelial cells convert T cells into CTLA-4+, B7-expressing CD8+ regulatory T cells. , 2006, Investigative ophthalmology & visual science.

[29]  J. Streilein,et al.  Pigment epithelial growth factor suppresses inflammation by modulating macrophage activation. , 2006, Investigative ophthalmology & visual science.

[30]  T. Hattori,et al.  Supplementation of CD4+CD25+ regulatory T cells suppresses experimental autoimmune uveoretinitis , 2006, British Journal of Ophthalmology.

[31]  A. Rothova,et al.  Distinct cytokine and chemokine profiles in the aqueous of patients with uveitis and cystoid macular edema. , 2006, American journal of ophthalmology.

[32]  R. Gress,et al.  B7+ iris pigment epithelium induce CD8+ T regulatory cells; both suppress CTLA-4+ T cells , 2006, The Journal of Immunology.

[33]  S. Sugita,et al.  B7+ Iris Pigment Epithelium Induce CD8+ T Regulatory Cells; Both Suppress CTLA-4+ T Cells12 , 2006, The Journal of Immunology.

[34]  F. Falciani,et al.  Multiplex bead immunoassay analysis of aqueous humor reveals distinct cytokine profiles in uveitis. , 2005, Investigative ophthalmology & visual science.

[35]  Y. Yu,et al.  CD8brightCD56+ T Cells Are Cytotoxic Effectors in Patients with Active Behçet’s Uveitis1 , 2005, The Journal of Immunology.

[36]  Douglas A Jabs,et al.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. , 2005, American journal of ophthalmology.

[37]  P. Sfikakis,et al.  Regression of neovascular age-related macular degeneration following infliximab therapy. , 2005, American journal of ophthalmology.

[38]  D. Gritz,et al.  Incidence and prevalence of uveitis in Northern California , 2004 .

[39]  A. Rothova,et al.  Endothelial cell activation and hypercoagulability in ocular Behçet's disease. , 2004, American journal of ophthalmology.

[40]  J. Schwartzkopff,et al.  CTLA-4+CD8+ T Cells That Encounter B7-2+ Iris Pigment Epithelial Cells Express Their Own B7-2 to Achieve Global Suppression of T Cell Activation1 , 2004, The Journal of Immunology.

[41]  D. Gritz,et al.  Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. , 2004, Ophthalmology.

[42]  A. Dick,et al.  Systemic CD4+ T cell phenotype and activation status in intermediate uveitis , 2004, British Journal of Ophthalmology.

[43]  D. Green,et al.  Presence of a transcriptionally active glucocorticoid receptor α in Lens epithelial cells , 2003 .

[44]  J. Streilein.  Ocular immune privilege: therapeutic opportunities from an experiment of nature , 2003, Nature Reviews Immunology.

[45]  C. Gorodezky,et al.  Classic Pars Planitis: strong correlation of class II genes with gender and some clinical features in Mexican Mestizos. , 2003, Human immunology.

[46]  S. Sugita,et al.  Iris Pigment Epithelium Expressing CD86 (B7-2) Directly Suppresses T Cell Activation In Vitro via Binding to Cytotoxic T Lymphocyte–associated Antigen 4 , 2003, The Journal of experimental medicine.

[47]  J. Streilein,et al.  Participation of pigment epithelium in ocular immune privilege. 3. Epithelia cultured from iris, ciliary body, and retina suppress T-cell activation by partially non-overlapping mechanisms , 2003, Ocular immunology and inflammation.

[48]  S. Urbaniak,et al.  Genetic Polymorphism of HLA DR in a Scottish Population of Patients with Pars Planitis , 2002, European journal of ophthalmology.

[49]  G. Adamus,et al.  EXPERIMENTAL AUTOIMMUNE UVEITIDES: MULTIPLE ANTIGENS, DIVERSE DISEASES , 2002, International reviews of immunology.

[50]  K. Geboes,et al.  An immunohistochemical study of the ‘snowbank’ in a case of pars planitis , 2002, Ocular immunology and inflammation.

[51]  A. Dick,et al.  CD69 expression on peripheral CD4+ T cells parallels disease activity and is reduced by mycophenolate mofetil therapy in uveitis. , 2001, Investigative ophthalmology & visual science.

[52]  H. Kaplan,et al.  The association of HLA class II with pars planitis. , 2001, American journal of ophthalmology.

[53]  R. Solana,et al.  Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells , 2001, Mechanisms of Ageing and Development.

[54]  M. Calonge,et al.  Pars planitis: epidemiology, treatment, and association with multiple sclerosis , 2001, Ocular immunology and inflammation.

[55]  T. Kezuka,et al.  Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 2. Generation of TGF-beta-producing regulatory T cells. , 2000, Investigative ophthalmology & visual science.

[56]  T. Kivelä,et al.  Search for autoantibodies against the HNK-1 carbohydrate epitope in the human eye in intermediate uveitis. , 2000, Acta ophthalmologica.

[57]  M. Mańczak,et al.  Epitope recognition and T cell receptors in recurrent autoimmune anterior uveitis in Lewis rats immunized with myelin basic protein , 2000, Journal of Neuroimmunology.

[58]  M. Takeuchi,et al.  Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact. , 2000, Investigative ophthalmology & visual science.

[59]  C. Chan,et al.  Inhibition of experimental melanin protein-induced uveitis (EMIU) by targeting nitric oxide via phosphatidylcholine-specific phospholipase C. , 1999, Journal of autoimmunity.

[60]  S. Lightman,et al.  Increased CD4+ expression and decreased IL-10 in the anterior chamber in idiopathic uveitis. , 1999, Investigative ophthalmology & visual science.

[61]  A. Rothova,et al.  Soluble ICAM-1 serum levels in patients with intermediate uveitis , 1999, The British journal of ophthalmology.

[62]  N. Bressler,et al.  Pars planitis: clinical features and class II HLA associations. , 1999, Ophthalmology.

[63]  G. Adamus,et al.  EAE TCR motifs and antigen recognition in myelin basic protein-induced anterior uveitis in Lewis rats. , 1998, Journal of immunology.

[64]  C. Hack,et al.  Elevated serum IL-8 levels are associated with disease activity in idiopathic intermediate uveitis , 1998, The British journal of ophthalmology.

[65]  J. E. Dickerson,et al.  Steroid-induced cataract: new perspective from in vitro and lens culture studies. , 1997, Experimental eye research.

[66]  J. Hillert,et al.  Distribution of HLA‐Dw2 in optic neuritis and multiple sclerosis indicates heterogeneity , 1996, Acta neurologica Scandinavica.

[67]  C. Foster,et al.  Referral patterns of uveitis in a tertiary eye care center. , 1996, Archives of ophthalmology.

[68]  C. Chan,et al.  Endotoxin induced uveitis in the mouse: susceptibility and genetic control. , 1995, Experimental eye research.

[69]  K. Barton,et al.  The kinetics of cytokine mRNA expression in the retina during experimental autoimmune uveoretinitis. , 1995, Cellular immunology.

[70]  S. Lightman,et al.  Oligoclonal activation of CD4+ T lymphocytes in posterior uveitis , 1995, Clinical and experimental immunology.

[71]  T. Rème,et al.  CD57+ T lymphocytes are derived from CD57− precursors by differentiation occurring in late immune responses , 1994, European journal of immunology.

[72]  J. Folk,et al.  The association of HLA-B8, B51, DR2, and multiple sclerosis in pars planitis. , 1993, Ophthalmology.

[73]  J. Folk,et al.  Long-term visual outcome and complications associated with pars planitis. , 1993, Ophthalmology.

[74]  R. Nussenblatt,et al.  Uveitis: Fundamentals and Clinical Practice , 1988 .

[75]  A. Friedman,et al.  A clinical and histopathological review of intermediate uveitis ("pars planitis"). , 1988, Bulletin of the New York Academy of Medicine.

[76]  D. Char,et al.  Activated T lymphocytes in uveitis. , 1988, The British journal of ophthalmology.

[77]  R. Nussenblatt,et al.  Clinical and immunopathological studies of pars planitis in a family. , 1988, The British journal of ophthalmology.

[78]  R. E. Smith,et al.  Changing patterns of uveitis. , 1987, American journal of ophthalmology.

[79]  R. Nussenblatt,et al.  International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. , 1987, American journal of ophthalmology.

[80]  D. Wakefield,et al.  Uveitis: aetiology and disease associations in an Australian population. , 1986, Australian and New Zealand journal of ophthalmology.

[81]  R. Nussenblatt,et al.  Kinetics of T-lymphocyte subsets in the eyes of Lewis rats with experimental autoimmune uveitis. , 1985, Cellular immunology.

[82]  R. Nussenblatt,et al.  T-lymphocyte subsets in experimental autoimmune uveitis. , 1985, Clinical immunology and immunopathology.

[83]  R. Brockhurst,et al.  Neovascular fundus abnormalities in peripheral uveitis. , 1982, Archives of ophthalmology.

[84]  W. Green,et al.  Pathology of pars planitis. , 1978, American journal of ophthalmology.

[85]  W. Sibley,et al.  Uveitis, perivenous sheathing and multiple sclerosis , 1978, Neurology.

[86]  R. E. Smith,et al.  Complications of chronic cyclitis. , 1976, American journal of ophthalmology.

[87]  R. Pruett,et al.  Fluorescein angiography of peripheral uveitis. , 1974, American journal of ophthalmology.

[88]  R. Porter.  Uveitis in association with multiple sclerosis. , 1972, The British journal of ophthalmology.

[89]  C. L. Giles.  Peripheral uveitis in patients with multiple sclerosis. , 1970, American journal of ophthalmology.

[90]  C. Schepens,et al.  Uveitis. IV. Peripheral uveitis: the complications of retinal detachment. , 1968, Archives of ophthalmology.

[91]  J. Sánchez-Román,et al.  [Clinical and epidemiological features and HLA association in patients with pars planitis]. , 2010, Medicina clínica (Ed. impresa).

[92]  S. Sugita,et al.  Role of ocular pigment epithelial cells in immune privilege , 2009, Archivum Immunologiae et Therapiae Experimentalis.

[93]  H. Aburatani,et al.  Retinal pigment epithelium-derived CTLA-2alpha induces TGFbeta-producing T regulatory cells. , 2008, Journal of immunology.

[94]  D. Green,et al.  Presence of a transcriptionally active glucocorticoid receptor alpha in lens epithelial cells. , 2003, Investigative ophthalmology & visual science.

[95]  L. Goodglick,et al.  BetaB1-crystallin: identification of a candidate ciliary body uveitis antigen. , 2003, Investigative ophthalmology & visual science.

[96]  E. Bettelli,et al.  Arch.Immunol.Ther.Exp. , 2000 .

[97]  Dennis P. Han,et al.  The association of HLA-DR15 and intermediate uveitis. , 1997, American journal of ophthalmology.

[98]  J. Winston,et al.  Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group. , 1996, American journal of ophthalmology.

[99]  J. Winston,et al.  Causes of Uveitis in the General Practice of Ophthalmology , 1996 .

[100]  S. Yoser,et al.  Pathology of intermediate uveitis. , 1992, Developments in ophthalmology.

[101]  J. Forrester,et al.  Immunocytochemical analysis of blood lymphocytes in uveitis , 1992, Eye.

[102]  R. Nussenblatt,et al.  Immunology of intermediate uveitis. , 1992, Developments in ophthalmology.

[103]  D. E. Henderly,et al.  Pars planitis. , 1986, Transactions of the ophthalmological societies of the United Kingdom.

[104]  R. Nussenblatt,et al.  Long-term culture of Muller cells from adult rats in the presence of activated lymphocytes/monocytes products. , 1985, Current eye research.

[105]  Y. de Kozak,et al.  S antigen-induced experimental autoimmune uveo-retinitis in rats. , 1981, Current eye research.

[106]  W. Green,et al.  Fibroglial proliferation in pars planitis. , 1975, Transactions of the ophthalmological societies of the United Kingdom.